Cargando…
Transgenic approaches for modifying the mammary gland to produce therapeutic proteins.
Bioengineering of the mammary gland to produce proteins of therapeutic and industrial value is the result of extensive investigation of the physiology of the mammary gland and the ability to generate transgenic animals. Targeting the expression of heterologous proteins to mammary tissue requires a t...
Autores principales: | Romagnolo, D, DiAugustine, R P |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
1994
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1567344/ https://www.ncbi.nlm.nih.gov/pubmed/9644191 |
Ejemplares similares
-
The mammary gland: protein factory of the future.
por: Romagnolo, D, et al.
Publicado: (1994) -
Neuroendocrinelike (small granule) epithelial cells of the lung.
por: DiAugustine, R P, et al.
Publicado: (1984) -
Secretory cells of the peripheral pulmonary epithelium as targets for toxic agents.
por: Hook, G E, et al.
Publicado: (1976) -
Effects of BRCA1 Transgene Expression on Murine Mammary Gland Development and Mutagen-Induced Mammary Neoplasia
por: Hoshino, Arichika, et al.
Publicado: (2007) -
Transcriptomic signature of Bexarotene (Rexinoid LGD1069) on mammary gland from three transgenic mouse mammary cancer models
por: Abba, Martin C, et al.
Publicado: (2008)